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Systemic lupus erythematosus (SLE) is a prototype autoimmune disease with a strong genetic involvement and ethnic differences.
Susceptibility genes identified so far only explain a small portion of the genetic heritability of SLE, suggesting that many more loci
are yet to be uncovered for this disease. In this study, we performed a meta-analysis of genome-wide association studies on SLE in
Chinese Han populations and followed up the findings by replication in four additional Asian cohorts with a total of 5,365 cases and
10,054 corresponding controls. We identified genetic variants in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated
with the disease. These findings point to potential roles of cell-cycle regulation, autophagy, and DNA demethylation in SLE pathogen-
esis. For the region involving TET3 and that involving CDKN1B, multiple independent SNPs were identified, highlighting a phenom-
enon that might partially explain the missing heritability of complex diseases.Introduction
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Figure 1. Flow Chart of the Experimental
Process and SNP Selection Criteriathis disease in that they have identified about 30 suscepti-
bility loci reaching genome-wide significance for SLE.4–11
However, these loci still only explain a small portion of
disease heritability. Studies with increased sample size,
with meta-analysis of existing GWASs, and of non-Euro-
pean populations are possible approaches that could
uncover some of the missing susceptibility variants for
SLE and move us toward a better understanding of the
disease and its intervention.
Previously, we conducted two GWASs on two different
Chinese populations, one in Hong Kong and one in main-
land China.4,8 We identified ETS1 (MIM 164720), WDFY4
(MIM 613316), IKZF1 (MIM 603023), RASGRP3 (MIM
609531), SLC15A4, TNIP1 (MIM 607714), and several
other loci as associated with SLE in Asian populations.
Interestingly, although many susceptibility genes are
confirmed in multiple ethnic groups,12–16 a number of
these genes were later on replicated only in Asian popula-
tions,17–20 raising the possibility of population specificity
for at least some of the findings.
In this study, we performed a meta-analysis of the two
existing GWASs on Chinese Han populations in Anhui
and Hong Kong4,8 and followed up the findings on four
additional Chinese and Thai cohorts with a total of 5,365
SLE cases and 10,054 controls matched geographically
and ethnically to cases in each cohort. We identified
TET3 (MIM 613555), CD80 (MIM 112203), ARID5B (MIM
608538), DRAM1 (MIM 610776), and CDKN1B (MIM
600778) as potential SLE susceptibility genes surpassing
genome-wide significance (p < 5 3 108). We also found
a number of loci with suggestive association with the
disease, providing useful information for future replica-42 The American Journal of Human Genetics 92, 41–51, January 10, 2013tions. We also examined association
signals in the meta-analysis data on
the known loci reported from studies
on European and other populations.
For some of the regions, a clear popu-
lation difference was indicated.
Subjects and Methods
The samples used in this study were
collected from Hong Kong, Anhui prov-
ince, China, and Bangkok, Thailand
(Figure 1). The Hong Kong cases are SLE-
affected individuals who were recruited
from five hospitals in Hong Kong: Queen
Mary Hospital, TuenMun Hospital, Queen
Elizabeth Hospital, Pamela Youde Nether-
sole Eastern Hospital, and Princess Mar-
garet Hospital. They are all of self-reported
Chinese ethnicity and live in Hong Kong.
Controls for the Hong Kong cohort arehealthy blood donors from the Hong Kong Red Cross (for the
Hong Kong replication panel) and individuals who participated
in other GWASs conducted in the University of Hong Kong and
who were genotyped on the same platform at the same time
(GWAS stage). SLE-affected individuals in the Anhui replication
panel 1 are all of self-reported Chinese ethnicity, live in Anhui
province, central China, and have visited the Department of
Rheumatology at Anhui Provincial Hospital and the First Affiliated
Hospital of Anhui Medical University in Hefei, Anhui province,
China.21 Controls were selected from a pool of healthy blood
donors recruited from Hefei, Anhui province, to match the corre-
sponding SLE cases in terms of age and sex. The samples for
the Anhui GWAS and Anhui replication panel 2 were obtained
from multiple hospitals in two geographic regions (central and
southern China),8 and the corresponding controls were ethnically
and geographically matched and clinically assessed to be without
SLE, other autoimmune disorders, systemic disorders, or family
history of autoimmune diseases. The Thai SLE cases are individuals
attending King Chulalongkorn Memorial Hospital, a tertiary
referral center in Bangkok, Thailand. Thai controls were recruited
from unrelated voluntary healthy donors from the same ethnic
background and geographic area as the Thai SLE cases. All cases
involved in this study have medical records documenting fulfill-
ment of the revised criteria of the American College of Rheuma-
tology for diagnosis of SLE.22 The studies were approved by the
respective institutional review boards at all the institutions listed
above, and all subjects gave informed consent.Genotyping
The two GWASs fromHong Kong and Anhui were conducted with
the use of the Illumina 610-Quad Human Beadchip array, as previ-
ously reported.4,8 In the first stage of a two-stage replication
process, 129 SNPs with a meta-analysis pmeta < 1 3 10
3 were
selected for replication. A single SNP was selected for each
200 kb region unless there was clear evidence supporting indepen-
dent association signals from the same locus. Of the 129 SNPs, 102
were successfully designed with the MassARRAY iPLEX Gold
system (Sequenom) and were genotyped on samples from the
Hong Kong replication panel, Anhui replication panel 1, and
Thai replication panel. SNPs violating Hardy-Weinberg equilib-
rium and samples and SNPs failing to achieve a call rate of 90%
or above were removed from further analysis, and 90 SNPs were
analyzed on a total of 2,605 cases and 3,384 controls from replica-
tion stage 1. Forty-five SNPs reaching a pcombined value of 13 10
5
by joint analysis of results from replication 1 and the GWAS were
selected for a second replication stage using samples from Anhui
replication panel 2, which involved 1,104 cases and 3,246
controls; this second stage also used the MassARRAY iPLEX Gold
system. A number of SNPs were also replicated by the TaqMan
SNP genotyping method with the use of Assays-on-Demand
probes and primers (Applied Biosystems). Genotyping accuracy
was examined by a comparison of the results from the TaqMan
SNP genotypingmethod and those from the SequenomMassArray
on a number of randomly chosen samples, and more than
99% concordance between the two platforms was achieved for
these SNPs.
Association Analysis
After a quality-control process removing SNPs with a low call
rate (<90%), low minor allele frequency (<1%), and violation of
Hardy-Weinberg equilibrium (p % 104), as well as removing
samples with a low call rate (<90%) and hidden relationship de-
tected with PLINK, 493,645 autosomal SNPs, 1,047 cases, and
1,205 controls from the Anhui cohort and 493,346 autosomal
SNPs, 612 cases, and 2,193 controls from the Hong Kong cohort
were analyzed. We also used PLINK to impute the GWAS data on
2,100,739 SNPs to deal with genotyping errors and missing data
and to seek a complete overlap of SNPs between the two data
sets; we used HapMap phase II CHB (Han Chinese in Beijing,
China) and JPT (Japanese in Tokyo, Japan) samples as the reference
panel and an INFO score of 0.8 as a cutoff.23 The samples from the
two cohorts were assessed for population stratification with Eigen-
strat24 (Figure S1, available online).
We used a weighted Z score method for the meta-analysis. To
combine results across different cohorts, we oriented the alleles
to the forward strand of the NCBI reference sequence of the
human genome to avoid ambiguity associated with C/G and A/T
SNPs. For each cohort, we converted association p values to Z
scores by taking into account the direction of association relative
to an arbitrary reference allele. We calculated a weighted sum of Z
scores by weighing each Z score by the square root of the quotient
of the effective sample size for each cohort over the sum of the
effective sample size for all cohorts combined. We then converted
the meta-analysis Z score to p values from a chi-square distribu-
tion. We used METAL25 to carry out the meta-analysis.
Joint association analysis, taking into account the effect of SNP
differences between cohorts, was conducted with the Cochran-
Mantel-Haenszel test, and homogeneity of effect size between
different cohorts and different stages of the study was tested
with Breslow-Day test (phet in Table 1); both tests were installed
in PLINK.23 A test of independent contribution toward disease
association for SNPs in a single locus was performed with logistic
regression conditional on the effect of the other SNPs in the
same region; this also took into account the potential differences
among cohorts. Association of the newly identified SNPs was
also tested conditionally on the effect of two most significantThe AmSNPs (rs9271366 and rs9275328) from the human-leukocyte-
antigen region.
Allele-Specific Transcription Quantification
Sixty-seven healthy individuals heterozygous for rs34330 were
chosen for a pyrosequencing assessment of the relative CDKN1B
mRNA levels derived from the two alleles, ‘‘C’’ and ‘‘T.’’ In the
meantime, DNA detection was used as a control for amplification
efficiency. In brief, total RNA was extracted from peripheral-blood
mononuclear cells (PBMCs) from each individual. RNA samples
were treated with DNAase for the elimination of genomic DNA
contamination before being reverse transcribed into cDNA with
oligo-dT primer. Together with genomic DNA from the same indi-
viduals, cDNA was then amplified by PCR with transcript-specific
primers. The cDNA and DNA PCR products were purified with
the QIAquick PCR purification kit and were then subjected to
allele-specific quantitative measuring by pyrosequencing. The
sequencing primers were designed with Pyrosequencing Assay
Design Software v.1.0. Reactions were performed on a Biotage
PSQ96MA machine, and allele quantification was analyzed with
PSQMA 2.1 software. The ratio of C:T allelic detection was per-
formed for both DNA and cDNA. A paired Student’s t test was
used for comparing the expression level from the ‘‘C’’ and the
‘‘T’’ alleles for this gene.
Analysis of Gene-Expression Data from Public
Databases
To explore the expression profile of the candidate genes identified
in this study in cells from SLE cases, we retrieved gene-expression
data of CD4þ T lymphocytes (GSE4588 andGSE10325), B lympho-
cytes (GSE4588 and GSE10325), and neutrophils and/or myeloid
cells (GSE27427 and GSE10325) from Gene Expression Omnibus
data sets from the NCBI. Differences in gene expression between
the cells from SLE-affected individuals and normal controls were
analyzed by an unpaired t test. Log2 (fold change) values were
also calculated from the signal-intensity ratio between cells from
SLE-affected individuals and cells from controls.Results
Meta-analysis
After a quality-control process, we performed a meta-anal-
ysis with METAL25 by using an effective sample size from
the two GWASs (940 for Hong Kong and 1,110 for Anhui)
as weight. Although the two Chinese populations don’t
fully overlap with each other in population structure, as
shown by the first two principal components analyzed
with Eigenstrat24 (Figure S1), the difference was small,
and a very modest genome inflation factor of 1.04 for
the meta-analysis was observed. Meta-analysis results
showed that variants from the major-histocompatibility-
complex region, TNFSF4 (MIM 603594), STAT4 (MIM
600558), TNFAIP3 (MIM 191163), IRF5 (MIM 607218),
BLK (MIM 191305), WDFY4, and ETS1 reached genome-
wide significance, together with SNPs from a locus in
2p13 (Figure 2 ). After we removed SNPs in and near the
known susceptibility loci (100 kb upstream and down-
stream of the susceptibility genes), deviation from the
diagonal line at the tail remained in a quantile-quantileerican Journal of Human Genetics 92, 41–51, January 10, 2013 43
Table 1. Results of Meta-analysis and Replication on the Identified Loci Associated with SLE
SNP Chr Risk Allele Gene
p Value
OR phetMETA HK Rep AH Rep 1 Thai AH Rep 2 Combined
Loci with Genome-wide Significance
rs6705628 2p13 C TET3 2.6 3 108 0.04 1.0 3 104 0.11 1.3 3 105 6.9 3 1017 0.75 0.43
rs4852324 2p13 T TET3 4.8 3 109 0.33 1.4 3 105 0.12 4.4 3 103 5.7 3 1014 0.79 0.05
rs6804441 3q13 A CD80 1.5 3 105 0.02 0.02 0.06 6.1 3 1012 2.5 3 1016 0.79 0.01
rs4948496 10q21 C ARID5B 2.4 3 104 5.7 3 103 0.03 1.8 3 105 0.01 5.1 3 1011 0.85 0.15
rs12822507 12p13 A CREBL2 1.5 3 104 0.12 0.09 0.99 8.0 3 105 2.2 3 108 0.86 0.39
rs10845606 12p13 C GPR19 1.1 3 105 0.16 1.8 3 107 0.05 5.8 3 107 3.8 3 1017 0.79 0.18
rs34330 12p13 C CDKN1B 2.3 3 104 5.6 3 103 1.5 3 103 0.02 9.0 3 104 4.8 3 1012 0.84 0.60
rs4622329 12q23 A DRAM1 9.5 3 105 0.68 1.5 3 106 9.6 3 105 0.02 9.4 3 1012 0.84 0.02
Loci with Suggestive Significance
rs10911390 1q31 T APOBEC4 1.5 3 104 0.14 0.20 0.31 0.06 6.4 3 106 1.13 0.75
rs1393820 2p13 G C1D 3.9 3 105 0.26 0.13 0.09 0.63 9.1 3 105 0.82 0.12
rs515983 2q22 T TMEM163 5.9 3 105 0.05 0.06 0.30 0.72 8.2 3 105 0.87 0.09
rs11717455 3p22 T SCN10A 2.4 3 105 0.02 0.86 0.23 0.07 6.9 3 106 0.71 0.10
rs2023532 4q24 C UBE2D3 2.3 3 104 0.29 0.01 0.22 0.60 1.1 3 105 0.80 0.30
rs2367894 5p13 G FYB 1.3 3 104 0.50 0.01 0.65 0.60 4.0 3 105 0.84 0.20
rs12529935 6q15 C BACH2 8.6 3 105 0.79 0.03 0.27 0.12 9.3 3 106 0.74 0.55
rs6957263 7q22 T PUS7 1.3 3 104 0.01 0.11 0.17 0.09 2.0 3 105 0.80 0.03
rs2252996 10q22 A SLC29A3 5.3 3 104 0.06 0.36 0.91 8.5 3 104 3.1 3 106 0.82 0.31
rs4910907 11p15 G RRM1 1.6 3 106 0.44 0.16 0.22 0.32 6.5 3 105 1.07 0.02
rs12917712 16p11 T SEZ6L2 8.6 3 106 0.03 0.03 0.68 0.84 7.1 3 106 1.07 0.19
rs12461589 19q12 C PDCD5 2.0 3 105 0.10 0.67 0.05 0.25 7.8 3 105 0.83 0.04
rs2303745 19p13.1 A DDA1 1.5 3 104 0.04 0.09 0.07 0.38 1.1 3 106 1.07 0.50
rs13333054 16q24 T IRF8a 6.9 3 104 3.0 3 104 0.12 0.12 N/A 4.6 3 105 1.06 0.02
rs2785197 11p13 C CD44a 7.7 3 104 0.75 3.4 3 103 0.98 2.6 3 104 1.9 3 107 0.81 0.18
The following abbreviations are used: chr, chromosome; META, results from the meta-analysis of the Hong Kong and Anhui GWASs; HK Rep, Hong Kong repli-
cation panel; AH Rep 1, Anhui replication panel 1; Thai, Thailand replication panel; AH Rep 2, Anhui replication panel 2; combined, p values from a combined
analysis of the results from the two GWASs and the four replication panels with the use of the Cochran-Mantel-Haenszel test of disease association conditional
on SNP-frequency differences among different panels; OR, odds ratio from the combined analysis; and phet, p values of the homogeneity test of ORs from the
six different panels with the use of the Breslow-Day test.
aPreviously reported loci.plot, indicating additional association signals not uncov-
ered from the previous work (Figure S2).
Association Signals from Meta-analysis on Previously
Reported Loci
We examined meta-analysis results on previously reported
loci to identify consistent cross-ethnicity associations or
potential population differences in susceptibility genes.
For easy observation, we grouped the results into three
tables according to meta-analysis p values. Among these
loci, 15 of them showed strong evidence of association
(pmeta < 1 3 10
4, Table S1). Five additional loci showed
suggestive evidence (1 3 104 < pmeta < 0.01, Table S2).
However, meta-analysis showed little support for the asso-44 The American Journal of Human Genetics 92, 41–51, January 10, 2ciation of several other genes reported in earlier studies on
populations of European ancestry or Asians (these genes
include IFIH1 [MIM 606951], PHRF1 [MIM 611780], PXK
[MIM 611450], TYK2 [MIM 176941], IL10 [MIM 124092],
JAZF1 [MIM 606246], PTPN22 [MIM 600716], and AFF1
[pmeta > 0.01, Table S3]) for the SNPs genotyped both
within the reported gene and 100 kb upstream and down-
stream, suggesting potential differences between different
ethnic groups, although this could also be caused by
incomplete coverage of the regions or lack of study power.
Interestingly, associations between SLE andWDFY4, ETS1,
DDX6 (MIM 600326), SLC15A4, RASGRP3, HIP1 (MIM
601767), and ZNF689/PRR14 were only detected from
studies on Asian populations (Table S4), highlighting the013
Figure 2. Manhattan Plot on the Meta-analysis Results of the Two SLE GWASs on Two Chinese Populations in Hong Kong and Anhui,
China
Known susceptibility genes are labeled in black, and genes identified in this study are labeled in red. The y axis is thelog10(pmeta) for the
autosomal SNPs from the two GWASs.significance of conducting association studies on non-
European populations. Further studies using imputation
and fine-mapping in different ethnic groups are needed
for clarifying the potential population differences in the
regions that showed apparent discrepancies.
Variants Reaching Genome-wide Significance after
Replication
A joint analysis of results from both GWAS and replication
stages identified a number of variants associated with SLE,
and some of them reached genome-wide significance.
In five loci, we identified eight SNPs reaching genome-
wide significance (3.8 3 1017 % pcombined % 2.2 3 10
8)
(Table 1, Figures 3 and 4, and more details in Table S5).
Three SNPs (rs12822507, rs10845606, and rs34330) were
located at 12p13 (Figures 3A and 4A–4C), and all reached
genome-wide significance and had minimum linkage
disequilibrium (LD) with each other (r2 % 0.17,
Figure S3). Their independent contribution to disease
susceptibility was also supported by logistic regression
conditional on the effect of the other two SNPs (Table
S6). The most significant signal was from rs10845606
(pcombined ¼ 3.8 3 1017, odds ratio [OR] ¼ 0.79), a SNP
located in an intron of G-protein-coupled receptor 19
(GPR19 [MIM 602927]), encoding an orphan receptor
that is highly expressed in human embryonic stem
cells26 but that otherwise has no known function. SNP
rs12822507 (pcombined ¼ 2.2 3 108, OR ¼ 0.86) is located
in an intron of cAMP-responsive element-binding protein-
like 2 (CREBL2 [MIM 603476]), which encodes a protein
that is well conserved during evolutionary courses and
shares high sequence similarity to CREB1 on a bZip
domain. CREBL2 might possess DNA-binding capability
and is found to interactwithCREB1.27Oneof the three vali-
dated 12p13 SNPs, rs34330 (pcombined ¼ 4.8 3 1012, OR ¼
0.84), is located in the 50 UTR of CDKN1B, and sequences
near the SNP might contain promoter activity.28The AmTwo other variants found in this study, rs4852324
(pcombined ¼ 5.7 3 1014, OR ¼ 0.79) and rs6705628
(pcombined ¼ 6.93 1017, OR ¼ 0.75), are located in the up-
stream region of tet methylcytosine dioxygenase 3 (TET3)
and downstream of deoxyguanosine kinase (DGUOK [MIM
601465]) at 2p13 (Figures 3B and 4D–4E). The two SNPs
have moderate LD (r2 % 0.56, Figure S6) with each other,
and there was evidence of independent contribution
of them toward disease association (Table S7). DGUOK
encodes a protein that is responsible for phosphoryla-
tion of purine deoxyribonucleosides in the mitochondrial
matrix and is highly expressed in immune cells. TET3 is
most abundant in myeloid and monocytic hematopoietic
cells and might play a role in malignant hematopoiesis.29
Alternatively, both SNPs are located within noncoding
RNA DGUOK-AS1 (DGUOK antisense RNA 1) and might
affect its expression or function.
SNP rs4948496 (pcombined ¼ 5.1 3 1011, OR ¼ 0.85) is
located in the fourth intron of ARID5B (AT-rich interactive
domain 5B [MRF1-like]) at 10q21 (Figures 3C and 4F).
More recently, rs10821944, a SNP 20 kb upstream of
rs4948496, was found to be associated with rheumatoid
arthritis (MIM 180300) in a Japanese population.30 The
two SNPs have moderate LD with each other (r2 ¼ 0.18),
and rs10821944 showed suggestive association with SLE
in our meta-analysis (pmeta ¼ 0.0012), but there was no
evidence of independent association of the effect of
rs4948496 by logistic regression (p ¼ 0.08 for rs10821944
and p ¼ 0.0074 for rs4948496 when conditional on the
effect of the other SNP). It remains to be determined
whether the same or different biological mechanisms are
involved in the two autoimmune diseases for this region.
Another potential candidate gene in this region is rhotekin
2 (RTKN2), which encodes a lymphocytic Rho-GTPase
effector that is exclusively expressed in lymphocytes
and might play a role in lymphocyte development and
function.31erican Journal of Human Genetics 92, 41–51, January 10, 2013 45
Figure 3. Association with SLE across the Five Regions
(A–E) Regional association plots show association from meta-analysis (log10(pmeta)) versus chromosomal position (kb) for all the SNPs
in a 500 kb region centered on the newly validated SNP. pmeta values are plotted for all SNPs, shaded white to red by the degree of LD (r
2;
see insets) with the validated SNP in the respective region (A, rs10845606; B, rs4852234; C, 4948496; D, rs6804441; and E, rs4622329).
Local recombination rates (cM/Mb, blue lines) estimated from HapMap CHB and JPT samples are plotted against the secondary y axis,
showing recombination hotspots across the region and haplotype blocks in between. Genes in the respective regions are labeled below
the plots. Chromosomal regions are as follows: (A) 12p13, (B) 2p13, (C) 10q21, (D) 3q13, and (E) 12q23.SNP rs6804441 (pcombined ¼ 2.5 3 1016, OR ¼ 0.79) is
located in a 40 kb LD block harboring a single gene
(CD80) at 3q13 (Figures 3D and 4G). CD80 encodes B7-1,
a membrane receptor that is on antigen-presenting cells
and that induces T cell proliferation and cytokine produc-
tion. At 12q23, we identified SNP rs4622329 to be associ-46 The American Journal of Human Genetics 92, 41–51, January 10, 2ated with SLE (pcombined ¼ 9.4 3 1012, OR ¼ 0.84), and
there are four genes (DRAM1, GNPTAB, SYCP3, and
CHPT1) in this region in a LD block of 230 kb (Figures 3E
and 4H). SNP rs4622329 is located about 4 kb downstream
of DRAM1 (DNA-damage-regulated autophagy modulator
1), which encodes a lysosomal membrane protein that is013
Figure 4. Forest Plot of Odds Ratios for the SNPs Surpassing Genome-wide Significance of 5 3 108 by Joint Analysis
The bars are 95% confidence intervals of odds ratios (ORs).required for the induction of autophagy and apoptosis and
is a target of TP53.32Suggestive Association Signals
In addition, we also identified 15 loci with suggestive asso-
ciation (1.9 3 107 % pcombined % 9.1 3 10
5) (Table 1)
with SLE, providing opportunities for confirming more
susceptibility genes in future studies through replica-
tions or meta-analyses. Among these 15 loci, 2 had been
recently reported. SNP rs2785197 is located upstream of
CD44 (MIM 107269) and has high LD (r2 ¼ 0.98) with
a SNP (rs2732552) identified in an earlier study.33
SNP rs13333054 is located downstream of IRF8 (MIM
601565), a susceptibility gene reported in a recent study
on European populations. However, it has little LD (r2 ¼
0.10 based on Hong Kong GWAS, Figure S4) with
rs2280381, the SNP that was reported in the previous study
on SLE.10 We also interrogated rs2280381 in our GWAS
stage, and it showedmarginal association by meta-analysis
(pmeta ¼ 0.035). It is likely that the association seen for
rs2280381 is dependent on rs13333054 in Asians.Allelic Differential Expression
Of the genetic variants reaching genome-wide signifi-
cance, rs34330 is located in the 50 UTR of CDKN1B. Thus,
allelic differential expression for this gene can be studied
with pyrosequencing, which is a method that can detect
small changes in expression between different alleles for
each individual. We compared the expression levels of
CDKN1B from the two alleles in PBMCs of healthy controls
heterozygous on rs34330. A significant difference was de-
tected with the risk allele (C allele), which correlatedThe Amwith a lower expression level of the gene (Figure S5). Differ-
ential expression of potential susceptibility genes was also
examined from public databases (Table S8) and might hint
at the potential functional roles of the identified suscepti-
bility variants, although these experiments were designed
for various purposes, and the results might be skewed by
unknown confounding factors.Discussion
Despite tremendous progress made in understanding
genetic susceptibility of complex diseases such as SLE,
the heritability explained by these variants is still very
limited. For a disease like SLE, which has apparent differ-
ences in prevalence and manifestations among major
ethnic groups, studies on non-European populations are
an efficient approach to making discoveries without solely
relying on increasing sample size. Findings in this study
focus our attention on several pathways that were not
uncovered in previous genetic studies and will undoubt-
edly broaden our understanding of the genetics of this
disease and eventually help develop personalized care
and risk prediction that are particularly suited to Asian
populations. The independent contributors in two of the
loci identified in this study also raised an important pros-
pect that might help explain the missing heritability of
complex diseases.
Among the potential candidate susceptibility genes
identified in this study, CDKN1B is well studied, and its
potential role in autoimmunity is supported by numerous
functional studies. CDKN1B encodes p27kip1, a cyclin-
dependent-kinase (CDK) inhibitor, which plays a criticalerican Journal of Human Genetics 92, 41–51, January 10, 2013 47
Figure 5. Potential Roles of the Identified Susceptibility Genes in SLE Etiology
Genes labeled in red are the ones identified in this study. Environmental triggers such as UV irradiation cause damage to cells. In affected
individuals, genetic variants inDRAM1,ATG5, andCDKN1B (encoding p27kip1) might lead to defects in apoptosis or autophagy and thus
increase exposure of nuclear autoantigens to the immune system. Interaction between CD28 and CD80 or CD86 plays a vital role in
T cell activation. Upon T cell activation, p27kip1 is phosphorylated and the CDK-cyclin complex is released, allowing cell-cycle progres-
sion. Upregulation of p27kip1 is essential for induction of tolerance. p27kip1 also plays a role in dendritic cell apoptosis. Activated autor-
eactive Th2 cells interact with B cells and induce B cell differentiation and production of autoantibodies. Autoreactive Th1 and Th17 cells
can exacerbate this process by secreting proinflammatory cytokines and chemokines, enhancing immune-complex deposition and end-
organ damage. Susceptibility genes such as CREBL2, ARID5B, and TET3 are involved in DNA and histone modification and might regu-
late expression of genes in T and B lymphocytes involved in autoimmunity.role in the inhibition of cell-cycle progression, especially in
T lymphocytes.34 p27kip1 is essential for the induction of
tolerance, a process believed to be at the center of autoim-
mune diseases such as SLE, and upregulation of p27kip1 was
found to correlate with induction of anergy in vitro and
tolerance in vivo.35,36 p27kip1 is also involved in dendritic
cell apoptosis,37 and the potential roles of the identified
susceptibility genes in this study in SLE etiology are de-
picted in Figure 5.
A significant difference was detected with the risk allele
(C allele) of SNP rs34330, located in the 50 UTR of CDKN1B;
it was found to be correlated with a lower expression level
of the gene (Figure S5). This is consistent with observed
downregulation of CDKN1B in PBMCs of individuals
with SLE (also see Table S8).38,39 It is noteworthy to point
out that the differences are very small, and further func-
tional studies are needed for confirming the potential
role of this SNP because a larger effect might be restricted
to specific cell types and/or responses to particular transac-
tivation signals or regulators. Alternatively, this SNP might
be an imperfect surrogate of another functional variant
with a stronger effect.48 The American Journal of Human Genetics 92, 41–51, January 10, 2For the 12p13 region (GPR19, CREBL2, and CDKN1B), as
well as for the 2p13 region between TET3 and DGUOK,
we identified multiple variants independently contrib-
uting to disease susceptibility. Given the design of this
study, which focused on finding previously undescribed
susceptibility regions, the exploration of independently
contributing variants in a given region is by no means
complete. We suspect that having multiple such variants
in a single locus could be more common than expected,
and this might partially explain the missing heritability
of complex diseases.
Another potential susceptibility gene, TET3, is ubiqui-
tously expressed, but it is most abundant in myeloid and
monocytic hematopoietic cells and might play a role in
malignant hematopoiesis.29 TET3 catalyzes conversion of
5-methylcytosine to 5-hydroxymethylcytosine and thus
plays an important role in DNA demethylation,40 a process
that might activate genes in T lymphocytes involved in au-
toreactivity. TET3 was found to be enriched specifically in
the male pronucleus, and TET3-mediated DNA hydroxyl-
ation is also involved in epigenetic reprogramming of the
zygotic paternal DNA after natural fertilization.41 Global013
hypomethylation has been observed in CD4þ T cells in
individuals with SLE.42,43 It is possible that demythylation
induced by TET3 might play a role in lymphocyte develop-
ment and induction of tolerance.
SNP rs4948496 is located in an intron of ARID5B, which
plays a role in the growth and differentiation of B-lympho-
cyte progenitors and possibly other lymphocytes. ARID5B
is a component of a histone-demethylase complex that re-
moves the repressive H3K9Me2 mark and activates tran-
scription of target genes.44 Knockout of Arid5b in mice
has been shown to cause transient immune abnormali-
ties.45 Previously, polymorphisms in ARID5B were found
to be associated with childhood acute lymphoblastic
leukemia (ALL [MIM 613065]).46,47 SNPs found to be asso-
ciated with ALL have little LD with rs4948496, indicating
that different biological processes might be involved in
the susceptibility of these two diseases.
CD80 encodes B7-1, a membrane receptor (on antigen-
presenting cells) that induces T cell proliferation and cyto-
kine production. Prolonged downregulation of CD80 on
B cells was observed in SLE-affected individuals successfully
treated with rituximab.48,49 CD80 was also found to be
associated with celiac disease (MIM 212750), multiple scle-
rosis (MIM 126200), and primary biliary cirrhosis (MIM
109720), which all have a strong autoimmune component.
Three SNPs found to be associated with these diseases were
interrogated in the GWAS stage, but none of them showed
association with SLE, again pointing to complexities in the
biological processes conferring disease susceptibility.
Identification of genetic variants near DRAM1 might
provide a missing link between genetic factors and envi-
ronmental stimulators for this disease. UV exposure has
long been suspected to be a trigger of lupusmanifestations.
It was found that induction of DNA damage by UV irradi-
ation stabilizes TP53 and induces DRAM1 expression,50
a key molecule in autophagy. The role of autophagy in
autoimmune diseases has long been suspected.51 Genetic
variants near ATG5 (MIM 604261), another important
player in autophagy, were previously found to be associ-
ated with SLE,7–9 and this association was also confirmed
in our meta-analysis (Table S1).
Genes of interest in the regions with suggestive suscepti-
bility include DDA1 (DET1- and DDB1-associated 1), also
an important gene in the autophagy network,52 and FYN
binding protein (FYB [MIM 602731]), which encodes
a protein involved in LCP2-signaling cascades in T cells
and in the expression of interleukin-2,53 a key cytokine
that is often reduced in individuals with SLE. C1D nuclear
receptor corepressor (C1D [MIM 606997]), which encodes
a DNA-binding and apoptosis-inducing protein that is
involved in DNA double-strand break repair inflicted by
UV irradiation,54 and ubiquitin-conjugating enzyme E2D
3 (UBE2D3 [MIM 602963]), which is involved in the activa-
tion of IkB kinase and NF-kB,55 are also potential candi-
dates for lupus susceptibility. And some of these genes
were found to be differentially expressed in the immune
cells of individuals with SLE (Table S8). Replication andThe Ammeta-analysis focusing on these regions in the future could
further improve our understanding of SLE susceptibility
and the disease mechanisms.
The susceptibility genes identified in this study suggest
a role for cell-cycle progression, apoptosis, autophagy,
and DNA and histone modification in SLE, broadening
our understanding of the genetics of this prototype
autoimmune disease. However, fine mapping, targeted
sequencing, and functional characterization are required
for firmly establishing the role of these genes. Findings in
this study also highlight potential differences in suscepti-
bility genes between different ethnic groups, which has
an impact not only on the understanding of the disease
but also on risk prediction and stratified patient care based
on ethnicity.Supplemental Data
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